Tagged With Gilead Sciences

Belgian biotech Galapagos surges after Gilead sinks another $5.1 billion into the firm


A new pill to treat HIV just got approved -- and it could shake up a $22 billion market


A cancer treatment that's part of 'a big new field of medicine' just got approved



The inside story of how a $15 billion deal for a revolutionary cancer treatment came together


A medical breakthrough that hacks genes to fight cancer just got approved, and it's the beginning of 'a big new field of medicine'


Here's why Gilead Sciences broke its dealmaking hiatus and splurged $12 billion on a cancer treatment



Gilead just handed a revolutionary kind of cancer treatment a $12 billon endorsement


Gilead just bought a cancer immunotherapy company for $12 billion


A promising Hep C program seems to be working -- and it could be a model for other countries


The FDA just approved a drug that treats all kinds of hepatitis C


A safer alternative to a once-daily HIV pill just got approved -- here's what you need to know about it


A safer alternative to a once-daily HIV pill just got approved -- here's what you need to know about it



10 game-changing drug companies that are about to revolutionise how we treat illness


There's a big catch to the HIV prevention pill some are calling '100% effective'


A pill that prevents HIV is working even better than people thought


A new HIV treatment could be even safer than the one available now



These 6 stocks are doing all the heavy lifting for the market right now -- and experts are nervous about it


Biotech giant Gilead could have some major problems with its 'wonder drug'


Biotech Giant Blows Away Expectations After Selling $US3.5 Billion Of Its 'Wonder Drug'